Dr. Peter Hotez on health: what the evidence says · JRE #1451

What the evidence says 01 / RECORD

Hotez's four-to-ten-times-flu figure, made in early 2020, matched estimates that several public-health experts were citing at the time (a March 2020 NPR report quoted a similar 5-to-10-times-flu range), so it reflected a real if provisional strand of expert opinion rather than a fringe claim. However, those early estimates relied on crude case-fatality-rate calculations from limited, symptomatic-biased testing data, and epidemiologists including John Ioannidis warned contemporaneously (STAT News, March 17, 2020) that the true infection fatality rate was highly uncertain and could be far lower once undetected mild and asymptomatic infections were counted. Later seroprevalence-based analysis (Ioannidis, Bulletin of the World Health Organization, 2021) found a global median COVID-19 infection fatality rate of about 0.27% (0.23% corrected), which the study explicitly describes as "much lower than estimates made earlier in the pandemic." Seasonal influenza's infection fatality rate is typically estimated around 0.1%, so the best subsequent evidence puts COVID-19's overall lethality multiplier at roughly two to three times flu in the general population, well below the four-to-ten-times figure Hotez cited, though rates were and remain much higher than that in older and high-risk groups. The claim's underlying death-toll math also did not fully anticipate later mitigating factors (behavior change, treatment improvements, vaccines) or the extent of under-ascertainment of mild cases, and was in that sense exaggerated relative to how the pandemic ultimately unfolded, even though it was consistent with genuine uncertainty and some expert views current in March 2020.